Overview

Affinity Chromatography slowing you down?

GORE Protein Capture Devices in 1.0 mL, 3.5 mL, 9 mL, 58 mL, 116 mL, 232 mL, 250 mL, 500 mL and 1L sizes.

Learn more

Traditional affinity chromatography technology has not kept pace with increased titers and other upstream process improvements, leading to bottlenecks and lower productivity in downstream protein A purification. To shorten processing times, traditional resin-based protein A is often over-sized or underutilized – simply to keep up.*

*Reference: “Disrupting Downstream Process Bottlenecks.” Genetic Engineering, June 14, 2018.

 

 

 

 

 

 

 

A cost-efficient platform for antibody production with comparable product quality to existing technologies. A flexible platform for single use manufacturing.

 

Graph of binding capacity of GORE Device (PROA103) vs standard technology

Representative dynamic binding capacity demonstrated with a 9 mL GORE Device (PROA103) versus a standard agarose bead-based technology, using a purified monoclonal antibody.

GORE Protein Capture Devices are approximately 6–10x faster than traditional (agarose bead-based) chromatography methods, which operate at typical residence times of 3–5 minutes (180–300 seconds).

Applications
Render of microsopic monocolonal antibody in blue and green

Designed for affinity purification in early drug discovery screening, late stage optimization, process development, clinical and routine bioprocessing for

  • monoclonal antibodies (mAbs)
  • next-generation molecules that utilize the Fc region for Protein A binding

The columns are compatible with standard chromatography systems.

 

Part Number Description Applications 
PROA101 1.0 mL Device Drug discovery
PROA102 3.5 mL Device Drug discovery
PROA103  9.0 mL Device     Drug discovery, late stage optimization, process development, early GMP applications
PROA201  58 mL Device Process development, clinical (GMP) applications  
PROA202  116 mL Device Clinical (GMP) applications  
PROA203  232 mL Device Clinical and Routine Manufacturing (GMP) applications
PROA301 250 mL Device Clinical and Routine Manufacturing (GMP) applications
PROA302 500 mL Device Clinical and Routine Manufacturing (GMP) applications
PROA303 1 L Device Clinical and Routine Manufacturing (GMP) applications

 

Performance

GORE Protein Capture Devices with immobilized Protein A* can improve throughput and yields in downstream purification by reducing overall process time through a combination of increased binding capacity and fast flow rates. These pre-packed columns use a unique membrane that offers high dynamic binding capacity at short residence time. Designed to increase the efficiency of protein A column purification processes, the Devices accommodate rapid cycle capability at low pressure drop, along with demonstrated ability to withstand multiple cleaning cycles. This increased productivity offers researchers the potential for a faster path to clinical trials.

  GORE Protein Capture Devices with Protein A (all sizes)
Dynamic binding capacity ≥ 30 mg/mL ≥ 40 mg/mL
Residence time 20 seconds 30 seconds
Number of cleaning cycles 0.2 N NaOH for 3 minutes up to 100 cycles 0.2 N NaOH for 3 minutes up to 100 cycles

*recombinant Protein A

RAPID, SCALABLE PROTEIN A CHROMATOGRAPHY ELUTION

The GORE Protein Capture Device scales across sizes without compromising binding capacity or speed to quickly and effectively capture antibodies as shown in this overlay of a 1 mL, 9 mL and 58 mL bind-elute curve and dynamic binding capacity graph.

Overlaid chromatogram showing 1.0 mL, 9.0 mL, and 58.0 mL device UV absorbance

Overlaid chromatogram showing 1 mL (blue), 9 mL (red) and 58 mL (green) UV absorbance. The difference in UV of harvest reflects different LC instruments.

Overlaid DBC10% comparison of 58 mL (red) and 250 mL (blue).

Overlaid DBC10% comparison of 58 mL (red) and 250 mL (blue).

Want complete technical and product performance information, including detailed test parameters, additional yield data, purity profiles and operating conditions?

CONTACT US        GET DATA SHEET

Technology

The GORE Protein Capture Devices with Protein A can streamline antibody purification processes because they incorporate a proprietary membrane composite.

Unlike traditional support matrices, the composite membrane bed maintains a linear relationship between pressure drop and a wide range of flow rates. Because this unique structure remains stable, the membrane bed is not vulnerable to collapse, channeling or alteration of the bed.

Performance under pressure
Pressure Drop for a 58 mL Device (PROA201)
Graph showing pressure drop vs. flow rate for GORE Device

Example pressure drop vs. flow rate relationship for a GORE Device when using phosphate buffer at room temperature. For reference, 116 mL/min equates to 30 seconds residence time.

Pressure drop consistency
Example of pressure drop vs. residence time consistency for the 58 mL (blue), 250 mL (red), and 500 mL (grey) when using phosphate buffer at room temperature.

Example of pressure drop vs. residence time consistency for the 58 mL (blue), 250 mL (red), and 500 mL (grey) when using phosphate buffer at room temperature. 

 

Materials of construction
 Components GORE PART NUMBER
PROA101
PROA102
PROA103
PROA201
PROA301
PROA202
PROA203
PROA302
PROA303
Device housing components Polypropylene Polypropylene and Polyether ether ketone (PEEK) primarily*
Frit material(s) Polypropylene Polyether ether ketone (PEEK)
Polyvinylidene fluoride (PVDF)
Membrane support matrix Proprietary composite
Ligand Recombinant Protein A
Connectors 10-32 threaded fittings (PROA101/PROA102)

10-32 coned thread port (PROA103)
5/16-24 Flat-bottom fittings (PROA201)

1/2-20 flat-bottom threaded fittings (PROA301)
3/4" Tri clamp
(0.984" (OD))

* For details:

GET DATA SHEET

For Validation

CONTACT US


 


 

Availability

GORE Protein Capture Devices are compatible with standard pre-packed column chromatography systems, and are available in sizes as listed in table below. Contact Gore for pricing and availability. These Devices for protein A purification are not available in all regions.

Part Number Description
PROA101 1.0 mL Device
PROA102 3.5 mL Device
PROA103 9.0 mL Device
PROA201 58 mL Device
PROA202 116 mL Device
PROA203 232 mL Device
PROA301 250 mL Device
PROA302 500 mL Device
PROA303 1 L Device

See Validation Guides for performance specifications and evaluations.

Regulatory Compliance and Quality

GORE Protein Capture Devices are manufactured following the applicable material quality and regulatory requirements, including relevant Good Manufacturing Processes as defined in the Gore PharmBIO quality system which is certified to ISO 13485 and ISO 15378. For current applicable compliance statements and quality control information:

CONTACT US

Resources

Recent News

Event

Gore PharmBIO at BioTalk EU 2024 in Berlin

September 9, 2024 - September 10, 2024

We’re excited to announce our participation as the official Digital Partner at BioTalk EU 2024, the premier annual event where the world’s top pharma and biopharma manufacturing leaders converge. The exclusive, invitation-only conference is held in Berlin September 9-10 and serves as the gateway to groundbreaking innovations and industry-shaping discussions.

Event

Gore PharmBIO showcased our latest innovations at the Bioprocessing Summit 2024

August 19, 2024 - August 22, 2024

The Gore PharmBIO team attended the Boston event, exploring opportunities for collaboration with industry leaders. We shared our latest innovations designed to support and enhance your bioprocessing projects.

Event

Join W. L. Gore & Associates for the Live + Virtual Bioprocessing Summit Europe

March 19, 2024 - March 21, 2024

Join W. L. Gore & Associates at BioProcessing Summit Europe, Europe’s Premier Conference to Optimize Your Bioprocesses.

Event

Unpacking the Resin Alternatives: Single-Use Protein a Tech That Can Reduce Costs and Accelerate Your Clinical Journey

March 14, 2024

Explore exclusive research and analysis on the future of protein A purification, the potential of single-use protein A membrane capture devices and the opportunities they offer over costly resin columns during antibody drug development.

View all News & Events

NOT INTENDED FOR USE in medical device or food contact applications or with radiation sterilization.